🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
This sponsor-open, investigator- and participant-blinded, multi-center stud...
Status
Completed
Location
Gastroenterology department, Second clinic of internal diseases
Start Date
2016-12-12
Trial ID
NCT02956850
This will be the first time GSK1325756 Solution for Infusion formulation th...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-12
Trial ID
NCT02169583
Patients with severe Haemophilia A need prophylactic factor VIII to reduce ...
Status
Completed
Location
Basingstoke & North Hampshire Hospital
Start Date
2013-04
Trial ID
NCT02697370
Treatments Being Tested
A Phase 1, randomized, single-blind, placebo-controlled, single dose, dose-...
Status
Completed
Location
TASMC
Start Date
2017-01-22
Trial ID
NCT02919800
Treatments Being Tested
This is a single-dose, open-label, two part, parallel group study. This stu...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-28
Trial ID
NCT01827657
Treatments Being Tested
The sponsor is trying to develop a medicine for infections that are not cur...
Status
Completed
Location
Early Phase Clinical Unit
Start Date
2014-06
Trial ID
NCT02162199
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00963768
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability, maximum...
Status
Completed
Location
City of Hope - Duarte
Start Date
2018-04-20
Trial ID
NCT03439280
Treatments Being Tested
This randomized study will be conducted in two parts to evaluate the safety...
Status
Completed
Location
Royal Melbourne Hospital
Start Date
2017-02-06
Trial ID
NCT03038113
Treatments Being Tested